The pace of change since Lumanity published Defining the Future of Mental Health: Strategic Imperatives for Psychedelic Therapies in fall 2025 has been striking. What was once considered fringe science, is now attracting rolling NDA submissions, blockbuster revenue forecasts, and serious commercial launch timelines. The question has fundamentally shifted. It’s no longer can these medicines work. The data is answering that. The question now is: are we ready for what comes next?

This is no longer a story about promise. It’s a story about preparation and the commercial, strategic, and operational decisions that will define who wins in this space and who gets left behind.

Read fresh insights and hear a collection of focused conversations exploring what the latest momentum in psychedelic therapies could mean for the journey from development to commercialization.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Explore the latest progress in psychedelics and hear directly from Lumanity's experts

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Sign me up to receive regular insights from Lumanity